Drug Facts
| Active ingredient (in each tablet) | Purpose |
| Ranitidine 75 mg (as ranitidine hydrochloride 84 mg) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . | Acid reducer |
The following Structured Product Label (SPL) was submitted to the FDA by Carilion Materials Management for the product Zantac 75 (NDC 68151-2584). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding drug facts, uses, warnings, do not use, ask a doctor before use if you have, stop use and ask a doctor if, directions, other information, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
| Active ingredient (in each tablet) | Purpose |
| Ranitidine 75 mg (as ranitidine hydrochloride 84 mg) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . | Acid reducer |
Allergy alert: Do not use if you are allergic to ranitidine or other acid reducers
If pregnant or breast-feeding, ask a health professional before use.
hypromellose, magnesium stearate, microcrystalline cellulose, iron oxide, titanium dioxide, triacetin
call 1-888-285-9159 (English/Spanish) M – F, 8:30 – 5 EST, or visit www.zantacotc.com
Read the directions, consumer information leaflet and warnings before use. Keep the carton. It contains important information.
Distributed by: Boehringer Ingelheim (BI) Consumer Health Care Products
Division of BI Pharmaceuticals, Inc., Ridgefield, CT 06877
© 2016, BI Pharmaceuticals, Inc. All rights reserved.
Product of Spain. Manufactured in Mexico.
Product: 68151-2584
NDC: 68151-2584-0 1 TABLET, COATED in a PACKAGE
* Please review the disclaimer below.